Using a smart watch and app to improve CPAP adherence in sleep apnea patients
Effect of Smart Watch and App on Positive Airway Pressure Adherence in Patients With Obstructive Sleep Apnea: A Randomized Controlled Trial
This study is testing if using a smart watch and an app can help people with sleep apnea stick to their CPAP treatment better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 92 (estimated) |
| Ages | 22 Years to 75 Years |
| Sex | All |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT05530265 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of a smart watch and a linked app in enhancing adherence to positive airway pressure (PAP) treatment among patients diagnosed with obstructive sleep apnea (OSA). The study employs a randomized controlled trial design to assess whether the technology can provide valuable health information, such as sleep patterns and oxygen saturation, which may motivate patients to use their PAP devices more consistently. By focusing on patients who have either never used PAP or have low adherence, the trial aims to identify innovative strategies to improve treatment outcomes for OSA. The intervention includes the use of a Samsung Health app in conjunction with the smart watch.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with obstructive sleep apnea who have either never used PAP therapy or have low adherence to it.
Not a fit: Patients who refuse PAP therapy or have conditions such as central sleep apnea or neuromuscular diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve adherence to PAP therapy, leading to better management of obstructive sleep apnea and enhanced patient health outcomes.
How similar studies have performed: While the use of technology to improve adherence in medical treatments is a growing field, this specific approach using a smart watch and app for PAP adherence in OSA is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosed with OSA (apnea-hyponea index \[AHI\])≥ 5 /h) by type 1 polysomnography * no prior use of PAP (CPAP or auto-adjusting PAP \[APAP\]), or no prior use of PAP within the previous 90 days in patients who had received PAP therapy, or current PAP users with average daily usage (all days) \< 4 hours within the previous 90 days Exclusion Criteria: * patients who refuse PAP therapy * patients who have used a smart watch (e.g., Galaxy Watch, Apple Watch, etc.) within the previous 90 days * patients with central sleep apnea or neuromuscular disease * patients receiving supplemental oxygen therapy due to underlying diseases including heart failure, stroke, chronic obstructive pulmonary disease, interstitial pulmonary disease, hypoventilation syndrome, or whose baseline oxygen saturation is less than 90% * patients with implanted cardiac pacemakers, defibrillators, or other electronic devices * patients who are inexperienced in using smartphones, apps, or smart watches * patients with an inability or unwillingness to provide informed consent
Where this trial is running
Seoul
- Seoul National University Hospital — Seoul, Korea, Republic of (Recruiting)
Study contacts
- Principal investigator: Jaeyoung Cho, M.D., Ph.D. — Seoul National University Hospital
- Study coordinator: Jaeyoung Cho, M.D., Ph.D.
- Email: apricot6@snu.ac.kr
- Phone: +82-2-2072-2503
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.